Autonomic Nervous System Drugs Practice Questions

Q: A drug 'X' is an alpha adrenergic blocker but paradoxically produces vasoconstriction. What is drug 'X'?

Ergotamine. The correct answer is **Ergotamine**. **1. Why Ergotamine is the correct answer:** Ergotamine is a non-selective alpha-adrenergic blocker, but it is unique because it acts as a **partial agonist** at alpha-receptors and 5-HT receptors [1]. While it can block the effects of stronger agonists (like norepinephrine), its intrinsic activity at these receptors causes significant **direct smooth muscle contraction** [1]. This results in peripheral vasoconstriction, which is the "paradoxical" effect referred to in the question [3]. This property is clinically utilized to treat acute migraine attacks by constricting dilated cerebral vessels [4]. **2. Analysis of Incorrect Options:** * **Phenoxybenzamine (A):** An irreversible, non-selective alpha-blocker [3]. It causes profound vasodilation and is used in the management of pheochromocytoma [2]. It does not possess vasoconstrictive properties. * **Prazosin (C):** A highly selective alpha-1 blocker. It causes vasodilation and is used for hypertension and BPH. It is notorious for the "first-dose phenomenon" (postural hypotension). * **Tolazoline (D):** An imidazoline derivative with competitive alpha-blocking activity. While it has some histamine-like effects, it primarily acts as a vasodilator and was historically used in persistent pulmonary hypertension of the newborn. **3. High-Yield Clinical Pearls for NEET-PG:** * **Ergotism (St. Anthony’s Fire):** Overdosage or chronic use of ergotamine leads to severe, persistent vasoconstriction resulting in gangrene of the extremities. * **Contraindication:** Ergotamine is strictly contraindicated in patients with Peripheral Vascular Disease (PVD) and Coronary Artery Disease (CAD) due to its vasoconstrictive nature [4]. * **Drug Interaction:** Avoid combining ergotamine with Triptans (5-HT 1B/1D agonists) within 24 hours, as this can lead to additive vasospasm.

Q: Succinylcholine acts to block neuromuscular transmission by:

Depolarizing the motor end plate of skeletal muscle. **Mechanism of Action** Succinylcholine (Suxamethonium) is the only **depolarizing neuromuscular blocker** used clinically. It acts as a nicotinic acetylcholine receptor (nAChR) agonist. Because it is not metabolized by acetylcholinesterase at the synapse, it persists longer than acetylcholine, causing persistent stimulation of the motor end plate. This leads to initial muscle fasciculations followed by a flaccid paralysis because the sodium channels remain in an inactivated state, preventing further action potentials (Phase I block). **Analysis of Options** * **Option A (Inhibiting cholinesterase):** This is the mechanism of drugs like Neostigmine or Organophosphates. Inhibiting cholinesterase actually *increases* acetylcholine levels, which would worsen a Phase I block caused by succinylcholine. * **Option B (Inhibiting the CNS):** Succinylcholine is a highly polar quaternary ammonium compound; it does not cross the blood-brain barrier and has no central effect. * **Option D (Blocking ACh release):** This is the mechanism of **Botulinum toxin** or aminoglycosides (at high doses). Succinylcholine acts postsynaptically, not presynaptically. **NEET-PG High-Yield Pearls** * **Metabolism:** Rapidly hydrolyzed by **Pseudocholinesterase** (Butyrylcholinesterase) in the plasma. * **Genetic Variation:** Patients with atypical pseudocholinesterase experience prolonged apnea (diagnosed via **Dibucaine Number**). * **Adverse Effects:** Hyperkalemia (dangerous in burn/trauma patients), Malignant Hyperthermia (treated with **Dantrolene**), and postoperative myalgia. * **Phase II Block:** With prolonged infusion, the membrane repolarizes but becomes desensitized to ACh, resembling a non-depolarizing block.

Q: Which direct-acting cholinomimetic agent, known for its lipid solubility, is used in the treatment of glaucoma?

Pilocarpine. ### Explanation **Correct Option: C. Pilocarpine** Pilocarpine is a **direct-acting cholinomimetic** (parasympathomimetic) alkaloid. It acts primarily on **M3 muscarinic receptors** in the eye, causing contraction of the sphincter pupillae (miosis) and the ciliary muscle. Contraction of the ciliary muscle increases the outflow of aqueous humor through the trabecular meshwork, thereby reducing intraocular pressure (IOP). Crucially, Pilocarpine is a **tertiary amine**, making it **lipid-soluble**, which allows it to penetrate the cornea effectively. **Incorrect Options:** * **A. Acetylcholine:** While it is a direct-acting agonist, it is rapidly degraded by cholinesterases and has very poor corneal penetration. It is used only for rapid miosis during intraocular surgery (e.g., cataract surgery). * **B. Physostigmine:** This is an **indirect-acting** cholinomimetic (acetylcholinesterase inhibitor). Although it is a tertiary amine and lipid-soluble, the question specifically asks for a *direct-acting* agent. * **C. Neostigmine:** This is an **indirect-acting** agent and a **quaternary ammonium** compound. Being polar/lipid-insoluble, it has poor ocular penetration and is not used for glaucoma. **High-Yield NEET-PG Pearls:** * **Drug of Choice (DOC):** Pilocarpine is the DOC for **Acute Angle Closure Glaucoma** (to pull the iris away from the angle), though it is now a second-line agent for Chronic Open Angle Glaucoma. * **Adverse Effects:** Brow ache (due to ciliary spasm), induced myopia, and retinal detachment (rare). * **Ocusert:** A specialized delivery system for Pilocarpine that provides a slow, sustained release over one week.

Q: Which of the following statements regarding depolarizing neuromuscular blocking drugs is true?

All of the above.. **Explanation:** Depolarizing neuromuscular blockers (DNMBs), primarily **Succinylcholine (Suxamethonium)**, act as nicotinic acetylcholine receptor (nAChR) agonists. They mimic acetylcholine but persist longer at the neuromuscular junction, leading to a prolonged state of depolarization. 1. **Option A (Unresponsiveness):** Succinylcholine causes a "Phase I block." By keeping the post-junctional membrane depolarized, the sodium channels remain in an inactivated state. Therefore, the muscle fiber cannot repolarize or respond to subsequent stimuli, leading to flaccid paralysis. 2. **Option B (Fasciculations):** Upon administration, the initial binding of Succinylcholine causes disorganized contractions of muscle units known as fasciculations. This is a hallmark clinical sign of DNMBs before paralysis sets in. 3. **Option C (Not reversed by Neostigmine):** Neostigmine is an acetylcholinesterase inhibitor. Increasing acetylcholine at the synapse actually **potentiates** a Phase I depolarizing block rather than reversing it. Furthermore, Succinylcholine is metabolized by pseudocholinesterase; Neostigmine inhibits this enzyme, further prolonging the drug's action. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Succinylcholine is the gold standard for **Rapid Sequence Induction (RSI)** due to its rapid onset (30–60s) and short duration (5–10 mins). * **Metabolism:** Degraded by **pseudocholinesterase** (plasma cholinesterase). Deficiency of this enzyme leads to prolonged apnea (Suxamethonium apnea). * **Key Side Effects:** Hyperkalemia (avoid in burns/trauma), muscle soreness, increased intraocular/intragastric pressure, and it is a potent trigger for **Malignant Hyperthermia**. * **Phase II Block:** Occurs with prolonged exposure or high doses; the block begins to resemble a non-depolarizing block and may then be antagonized by Neostigmine.

Q: Botulinum toxin acts by:

Presynaptic inhibition of release of acetylcholine. **Explanation:** Botulinum toxin, produced by the bacterium *Clostridium botulinum*, is a potent neurotoxin that causes flaccid paralysis by targeting the neuromuscular junction. **Mechanism of Action (Why B is correct):** The toxin acts as a zinc-dependent endopeptidase. Once internalized into the presynaptic nerve terminal, it cleaves **SNARE proteins** (specifically SNAP-25, synaptobrevin, or syntaxin). These proteins are essential for the docking and fusion of acetylcholine-containing vesicles with the presynaptic membrane. By destroying these proteins, the toxin prevents the exocytosis of acetylcholine into the synaptic cleft, leading to **presynaptic inhibition of acetylcholine release**. **Analysis of Incorrect Options:** * **Option A:** This describes the mechanism of certain spider venoms (like Black Widow venom/α-latrotoxin), which cause massive neurotransmitter release, leading to muscle spasms. * **Options C & D:** Botulinum toxin acts specifically on cholinergic (acetylcholine) transmission at the peripheral neuromuscular junction and autonomic ganglia. It does not have a direct mechanism involving GABA, which is the primary inhibitory neurotransmitter in the Central Nervous System (CNS). **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Causes "Floppy Baby Syndrome" (infant botulism via honey ingestion) and symmetric descending paralysis. * **Therapeutic Uses:** Used for focal dystonias (e.g., blepharospasm, torticollis), achalasia cardia, hyperhidrosis, and cosmetic reduction of wrinkles. * **Contrast with Tetanus Toxin:** While both cleave SNARE proteins, Tetanus toxin undergoes retrograde axonal transport to the CNS and inhibits **GABA/Glycine** release from Renshaw cells, causing spastic paralysis.

Q: Which adrenergic beta-receptor subtype is primarily responsible for lipolysis in fat cells?

Beta-3. ### Explanation **Correct Option: D (Beta-3)** The **Beta-3 ($\beta_3$) receptor** is the primary adrenergic receptor subtype located in adipose tissue (both white and brown fat) [1], [3]. Activation of these receptors by norepinephrine or selective agonists stimulates the enzyme **adenylyl cyclase**, increasing intracellular cAMP. This activates **hormone-sensitive lipase**, which catalyzes the breakdown of triglycerides into free fatty acids and glycerol—a process known as **lipolysis** [1], [3]. In brown adipose tissue, $\beta_3$ stimulation also mediates **thermogenesis** [3]. **Analysis of Incorrect Options:** * **Alpha-1 ($\alpha_1$):** These are primarily Gq-coupled receptors found in vascular smooth muscle, causing vasoconstriction and pupillary dilation (mydriasis). They do not play a significant role in lipid metabolism. * **Alpha-2 ($\alpha_2$):** These are inhibitory (Gi-coupled) receptors. While they are present on fat cells, their activation actually **inhibits lipolysis** by decreasing cAMP levels [2]. * **Beta-1 ($\beta_1$):** These are predominantly found in the **heart** (increasing heart rate and contractility) and the **juxtaglomerular apparatus** of the kidney (increasing renin release) [1]. While they have a minor metabolic role, $\beta_3$ is the specific and primary mediator for lipolysis [3]. **High-Yield NEET-PG Pearls:** * **Mirabegron:** A selective $\beta_3$ agonist used clinically for the treatment of **overactive bladder** (it relaxes the detrusor muscle). * **Location Summary:** * $\beta_1$: Heart (1 heart) * $\beta_2$: Lungs/Bronchi (2 lungs) and Uterus (Tocolysis) * $\beta_3$: Adipose tissue (Lipolysis) and Detrusor muscle (Relaxation) [3] * **Metabolic effects of Catecholamines:** Generally, $\beta$-receptors increase blood glucose (glycogenolysis/gluconeogenesis) and free fatty acids (lipolysis) to provide energy during "fight or flight" responses.

Q: Which of the following substances can cross the blood-brain barrier?

Physostigmine. **Explanation:** The ability of a drug to cross the **Blood-Brain Barrier (BBB)** depends primarily on its lipid solubility and ionization state. To penetrate the CNS, a molecule must be **lipophilic** and **non-ionized**. **Why Physostigmine is Correct:** Physostigmine is a **tertiary amine** anticholinesterase. Unlike quaternary compounds, tertiary amines are uncharged (non-ionized) and highly lipid-soluble, allowing them to readily cross the BBB. This makes Physostigmine the drug of choice for treating central anticholinergic toxicity (e.g., Atropine poisoning). **Analysis of Incorrect Options:** * **Dopamine (A):** Although it is a neurotransmitter, dopamine is highly polar and does not cross the BBB. This is why **Levodopa** (a precursor that uses a transport carrier) is used in Parkinson’s disease instead of dopamine itself. * **Propranolol (B):** *Note: Propranolol actually DOES cross the BBB due to its high lipophilicity (causing side effects like vivid dreams).* However, in the context of this specific question format comparing it to the definitive "tertiary vs. quaternary" pharmacological principle of Physostigmine, Physostigmine is the classic textbook answer for "crossing the BBB" in cholinergic pharmacology. * **Glycopyrrolate (C):** This is a **quaternary ammonium** compound. It is permanently charged (ionized), making it lipid-insoluble and unable to cross the BBB. It is used when peripheral anticholinergic effects are desired without CNS side effects. **NEET-PG High-Yield Pearls:** 1. **Tertiary Amines (Cross BBB):** Physostigmine, Atropine, Scopolamine, Rivastigmine. 2. **Quaternary Amines (Do NOT cross BBB):** Neostigmine, Pyridostigmine, Edrophonium, Glycopyrrolate. 3. **Clinical Rule:** Use **Physostigmine** for Atropine poisoning (Central + Peripheral symptoms); use **Neostigmine** for Myasthenia Gravis (Peripheral action only).

Q: What is the effect of atropine on the eye?

Passive mydriasis. **Explanation:** The correct answer is **Passive Mydriasis**. To understand this, we must look at the autonomic control of the iris muscles: 1. **Mechanism of Action:** Atropine is a competitive muscarinic antagonist. In the eye, it blocks the **M3 receptors** on the **Sphincter Pupillae** (circular muscle). Normally, Parasympathetic stimulation causes this muscle to contract, leading to miosis. By blocking this action, atropine causes the muscle to relax. The pupil dilates because the opposing muscle (Dilator Pupillae) is now unopposed. This is termed **"Passive"** because the dilation results from relaxation of the constrictor, not active contraction of the dilator. **Analysis of Options:** * **Active Mydriasis (Option A):** This occurs when **Alpha-1 agonists** (like Phenylephrine) directly stimulate the **Dilator Pupillae** (radial muscle) to contract. * **Miosis (Option C):** This is pupillary constriction caused by parasympathomimetics (like Pilocarpine) or opioid toxicity. * **Pinpoint Pupil (Option D):** This is extreme miosis, typically seen in Organophosphate poisoning or Pontine hemorrhage. **High-Yield NEET-PG Pearls:** * **Cycloplegia:** Atropine also blocks M3 receptors on the **Ciliary Muscle**, leading to loss of accommodation (paralysis of near vision). * **Duration:** Atropine has the longest duration of action among mydriatics (7–10 days). For refraction testing in adults, shorter-acting agents like **Tropicamide** are preferred. * **Contraindication:** Atropine is strictly contraindicated in **Narrow-Angle Glaucoma**, as mydriasis can further obstruct the aqueous outflow facility.

Question 1

A drug 'X' is an alpha adrenergic blocker but paradoxically produces vasoconstriction. What is drug 'X'?

Accepted Answer

Ergotamine

Answer

Phenoxybenzamine

Answer

Prazosin

Answer

Tolazoline

Question 2

Succinylcholine acts to block neuromuscular transmission by:

Accepted Answer

Depolarizing the motor end plate of skeletal muscle

Answer

Inhibiting cholinesterase

Answer

Inhibiting the central nervous system

Answer

Blocking the release of acetylcholine at the end plate

Question 3

Which direct-acting cholinomimetic agent, known for its lipid solubility, is used in the treatment of glaucoma?

Accepted Answer

Pilocarpine

Answer

Acetylcholine

Answer

Physostigmine

Answer

Neostigmine

Question 4

Which of the following statements regarding depolarizing neuromuscular blocking drugs is true?

Accepted Answer

All of the above.

Answer

The depolarized muscle fibers are unresponsive to other stimuli.

Answer

Causes muscular fasciculations.

Answer

Is not reversed by neostigmine.

Question 5

Which alpha-blocker is useful in Benign Prostatic Hyperplasia (BPH)?

Accepted Answer

Prazosin

Answer

Phentolamine

Answer

Tolazoline

Answer

Phenoxybenzamine

Question 6

Botulinum toxin acts by:

Accepted Answer

Presynaptic inhibition of release of acetylcholine

Answer

Presynaptic release of acetylcholine

Answer

GABA mimetic

Answer

GABA antagonist

Question 7

Which adrenergic beta-receptor subtype is primarily responsible for lipolysis in fat cells?

Accepted Answer

Beta-3

Answer

Alpha-1

Answer

Alpha-2

Answer

Beta-1

Question 8

Which of the following substances can cross the blood-brain barrier?

Accepted Answer

Physostigmine

Answer

Dopamine

Answer

Propranolol

Answer

Glycopyrrolate

Question 9

What is the effect of atropine on the eye?

Accepted Answer

Passive mydriasis

Answer

Active mydriasis

Answer

Miosis

Answer

Pinpoint pupil

Question 10

Which one of the following sites is characterized by adrenergic neurohumoral transmission?

Accepted Answer

Sympathetic fibers in the adrenal medulla

Answer

Parasympathetic preganglionic fibers

Answer

Sympathetic postganglionic fibers

Answer

Synaptic fibers in the eccrine gland

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?